Postpartum TSH Changes and Management
Women at high risk for postpartum thyroid dysfunction should be screened with TSH at 6-12 weeks postpartum, with the hypothyroid phase typically occurring between 3-8 months (most commonly at 6 months) and lasting 4-6 months. 1
Expected Postpartum TSH Changes
Postpartum Thyroiditis (PPT) Pattern
Biphasic pattern: PPT classically presents with an initial hyperthyroid phase followed by a hypothyroid phase, though some women experience only the hypothyroid phase 1
Timing of hypothyroid phase: TSH elevation typically occurs between 3-8 months postpartum, with peak incidence at 6 months 1
Duration: The hypothyroid phase usually lasts 4-6 months, though 20-64% of women develop permanent hypothyroidism during long-term follow-up 1
Earlier onset: Hypothyroidism tends to occur earlier when preceded by thyrotoxicosis compared to when it occurs alone 1
High-Risk Groups Requiring TSH Screening
Screen the following populations at 6-12 weeks postpartum: 1
- Women with positive thyroid peroxidase (TPO) antibodies 1
- Women with type 1 diabetes mellitus 1
- Women with prior history of postpartum thyroiditis 1
- Women with Graves' disease in remission (screen at 3-6 months for recurrence) 1
- Women with chronic viral hepatitis 1
Treatment Approach
Asymptomatic Women with Mild TSH Elevation
TSH above reference range but <10 mIU/L: Women not planning subsequent pregnancy do not necessarily require immediate intervention but should be remonitored in 4-8 weeks 1
Persistent elevation: When TSH remains above the reference range on repeat testing, initiate levothyroxine treatment 1
Symptomatic Women or Those Planning Pregnancy
Treat immediately with levothyroxine if TSH is above normal range, regardless of severity, in women who are symptomatic or attempting pregnancy 1
Common symptoms: Fatigue, loss of concentration, poor memory, constipation, and possibly depression are most frequently experienced during the hypothyroid phase 1
Postpartum Depression Screening
Screen all women with postpartum depression for hypothyroidism, as hypothyroidism is a potentially reversible cause of depression 1
Note: The evidence does not consistently support an association between PPD and either PPT or thyroid antibody positivity alone, but screening is warranted given the treatability of hypothyroidism 1
Long-Term Follow-Up
Annual Monitoring
Women with history of PPT require annual TSH testing due to markedly increased risk of developing permanent primary hypothyroidism in the 5-10 years following the PPT episode 1
Persistent abnormalities: Even after recovery from hypothyroidism, ultrasonographic and functional abnormalities persist, reflecting underlying chronic autoimmune thyroiditis 1
Recovery Patterns
The majority of women return to euthyroidism by the end of the first postpartum year 1
However, a small percentage never recover from the initial hypothyroid phase, and long-term progression to permanent hypothyroidism is common 1
Clinical Pitfalls to Avoid
Do not perform universal screening: Routine thyroid function screening is not recommended for asymptomatic women without risk factors 2
Differentiate from Graves' disease: In women presenting with thyrotoxicosis postpartum, distinguish new-onset or recurrent Graves' disease from PPT, as management differs significantly 2
Consider difficulty lactating: Check serum TSH in women experiencing difficulty with lactation, as this may indicate thyroid dysfunction 2
Avoid premature reassurance: Do not assume transient dysfunction will resolve without follow-up, given the high rate of progression to permanent hypothyroidism 1